Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program von King, Brett, Soung, Jennifer, Tziotzios, Christos, Rudnicka, Lidia, Joly, Pascal, Gooderham, Melinda, Sinclair, Rodney, Mesinkovska, Natasha A., Paul, Carle, Gong, Yankun, Anway, Susan D., Tran, Helen, Wolk, Robert, Zwillich, Samuel H., Lejeune, Alexandre

Volltext

Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database von George, Prethibha, Jagun, Oladayo, Liu, Qing, Wentworth, Charles, Napatalung, Lynne, Wolk, Robert, Anway, Susan, Zwillich, Samuel H.

Volltext

Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program von King, Brett, Soung, Jennifer, Tziotzios, Christos, Rudnicka, Lidia, Joly, Pascal, Gooderham, Melinda, Sinclair, Rodney, Mesinkovska, Natasha A., Paul, Carle, Gong, Yankun, Anway, Susan D., Tran, Helen, Wolk, Robert, Zwillich, Samuel H., Lejeune, Alexandre

Volltext

Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database von George, Prethibha, Jagun, Oladayo, Liu, Qing, Wentworth, Charles, Napatalung, Lynne, Wolk, Robert, Anway, Susan, Zwillich, Samuel H.

Volltext

A Strategy for Risk Management of Drug-Induced Phospholipidosis von Chatman, Linda A., Morton, Daniel, Johnson, Theodore O., Anway, Susan D.

Volltext

Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program von Adis Journals on behalf of, King, Brett, Soung, Jennifer, Tziotzios, Christos, Rudnicka, Lidia, Joly, Pascal, Gooderham, Melinda, Sinclair, Rodney, Mesinkovska, Natasha A., Paul, Carle, Gong, Yankun, Anway, Susan D., Tran, Helen, Wolk, Robert, Zwillich, Samuel H., Lejeune, Alexandre

Volltext bestellen

Integrated Safety Analysis of Ritlecitinib for the Treatment of Alopecia Areata (AA) From the Phase 2 and Phase 3 ALLEGRO Clinical Trial Program von King, Brett, Soung, Jennifer, Tziotzios, Christos, Rudnicka, Lidia, Joly, Pascal, Gooderham, Melinda, Sinclair, Rodney, Anway, Susan, Wajsbrot, Dalia, Lejeune, Alexandre, Zwillich, Samuel

Volltext

Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database von Adis Journals on behalf of, George, Prethibha, Jagun, Oladayo, Liu, Qing, Wentworth, Charles, Napatalung, Lynne, Wolk, Robert, Anway, Susan, Zwillich, Samuel H

Volltext bestellen